Cetera Investment Advisers
ALDX icon

Cetera Investment Advisers’s Aldeyra Therapeutics ALDX Stock Holding History

Cetera Investment Advisers’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
+14,699
New +$25.3K ﹤0.01% 4816
2024
Q4 		– Sell
-19,012
Closed -$102K – 3772
2024
Q3 		$102K Buy
19,012
+1,035
+6% +$4.93K ﹤0.01% 3534
2024
Q2 		$59.5K Hold
17,977
– – ﹤0.01% 3584
2024
Q1 		$58.8K Buy
+17,977
New +$59.1K ﹤0.01% 3556

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Cetera Investment Advisers's ALDX Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 14,699 shares worth $31.3K. The stake represents ﹤0.01% of the portfolio and ranks #4816 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in ALDX as recently as Q3 2024.

Cetera Investment Advisers first reported a position in ALDX in Q1 2024 and has held it in 4 quarters since. The position peaked at $102K in Q3 2024. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Cetera Investment Advisers held 14,699 shares of Aldeyra Therapeutics worth $31.3K as of Q2 2026.
  • Aldeyra Therapeutics was a new Cetera Investment Advisers position in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4816 holding.
  • Cetera Investment Advisers first reported a position in Aldeyra Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Aldeyra Therapeutics position peaked at $102K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.